This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Matthew Hegreness
Matthew Hegreness
Associate
Washington +1 202 662 5418 mhegreness@cov.com Download V-card

Matthew Hegreness is an associate in the firm’s Washington, DC office, specializing in the regulation of food, pharmaceuticals, dietary supplements, and cosmetics.  He counsels clients on compliance with state and federal regulatory regimes, especially those of the Food and Drug Administration and Federal Trade Commission.  Dr. Hegreness also provides advice and regulatory due diligence to support the corporate transactions and securities filings of the firm’s life sciences clients.  Dr. Hegreness’s legal counsel reflects a strong grasp of underlying scientific issues, developed during his years as a research biologist.

  • Advised companies on the labeling and advertising of food, dietary supplements, medical devices, and cosmetics.
  • Counseled businesses on issues of drug and medical device approval, and on Hatch-Waxman exclusivity strategies.
  • Advised companies on issues of scientific substantiation of advertising claims, including evaluation of clinical trials.
  • Advised pharmaceutical trade association on novel questions of state and federal law.
  • Represented client in FTC administrative proceedings related to the advertising of food and dietary supplements.
  • Advised businesses of regulatory risks associated with the purchase of biotechnology and pharmaceutical companies.
  • Represented innovator pharmaceutical company in Hatch-Waxman patent litigation.
  • Defended manufacturer of organic cosmetics in state and federal false advertising litigation.

Previous Experience

  • Member of the Yale Supreme Court Advocacy Clinic; co-wrote two merit briefs and a petition of certiorari to the U.S. Supreme Court (2011-2012).
  • Scientific researcher and Ph.D. student at Harvard in the laboratories of systems biologist Roy Kishony and population geneticist Daniel Hartl (2003-2008).